Pages that link to "Q36622848"
Jump to navigation
Jump to search
The following pages link to Cerebral β-amyloid deposition predicts HIV-associated neurocognitive disorders in APOE ε4 carriers (Q36622848):
Displaying 50 items.
- Natural Products as Anti-HIV Agents and Role in HIV-Associated Neurocognitive Disorders (HAND): A Brief Overview (Q26770401) (← links)
- Chronic inflammation and the role for cofactors (hepatitis C, drug abuse, antiretroviral drug toxicity, aging) in HAND persistence (Q26825762) (← links)
- Genetic, transcriptomic, and epigenetic studies of HIV-associated neurocognitive disorder (Q26865707) (← links)
- The Chronicity of HIV Infection Should Drive the Research Strategy of NeuroHIV Treatment Studies: A Critical Review (Q28066725) (← links)
- Amyloid β: one of three danger-associated molecules that are secondary inducers of the proinflammatory cytokines that mediate Alzheimer's disease (Q28384947) (← links)
- β-Amyloid1-42, HIV-1Ba-L (clade B) infection and drugs of abuse induced degeneration in human neuronal cells and protective effects of ashwagandha (Withania somnifera) and its constituent Withanolide A (Q28545117) (← links)
- Cytomegalovirus and HIV: A Dangerous Pas de Deux (Q30245376) (← links)
- The longitudinal and interactive effects of HIV status, stimulant use, and host genotype upon neurocognitive functioning (Q30410418) (← links)
- PET brain imaging in HIV-associated neurocognitive disorders (HAND) in the era of combination antiretroviral therapy (Q31153188) (← links)
- HIV-1 stimulates nuclear entry of amyloid beta via dynamin dependent EEA1 and TGF-β/Smad signaling (Q33604503) (← links)
- HIV protease inhibitor exposure predicts cerebral small vessel disease (Q33807507) (← links)
- Effects of APOE ε4, age, and HIV on glial metabolites and cognitive deficits (Q33961790) (← links)
- Host genetic factors predisposing to HIV-associated neurocognitive disorder (Q34001122) (← links)
- Activation of TRPML1 clears intraneuronal Aβ in preclinical models of HIV infection (Q34067393) (← links)
- Ashwagandha (Withania somnifera) reverses β-amyloid1-42 induced toxicity in human neuronal cells: implications in HIV-associated neurocognitive disorders (HAND). (Q35023273) (← links)
- No association between Apoε4 alleles, HIV infection, age, neuropsychological outcome, or death (Q35058529) (← links)
- Transcriptional profile of HIV-induced nuclear translocation of amyloid β in brain endothelial cells (Q35072502) (← links)
- Cerebrospinal fluid (CSF) CD8 T-cells that express interferon-gamma contribute to HIV associated neurocognitive disorders (HAND) (Q35125862) (← links)
- APOE ε4 moderates abnormal CSF-abeta-42 levels, while neurocognitive impairment is associated with abnormal CSF tau levels in HIV individuals - a cross-sectional observational study (Q35276365) (← links)
- Elevated rates of mild cognitive impairment in HIV disease (Q36200027) (← links)
- Interacting partners of macrophage-secreted cathepsin B contribute to HIV-induced neuronal apoptosis. (Q36259524) (← links)
- Brain and liver pathology, amyloid deposition, and interferon responses among older HIV-positive patients in the late HAART era. (Q36284359) (← links)
- The adaptive immune system restrains Alzheimer's disease pathogenesis by modulating microglial function (Q36659056) (← links)
- Accelerated epigenetic aging in brain is associated with pre-mortem HIV-associated neurocognitive disorders (Q36989549) (← links)
- Lipid Profiles and APOE4 Allele Impact Midlife Cognitive Decline in HIV-Infected Men on Antiretroviral Therapy (Q37284168) (← links)
- HIV associated neurocognitive disorders in the modern antiviral treatment era: prevalence, characteristics, biomarkers, and effects of treatment. (Q38223328) (← links)
- Apolipoprotein E4 Suppresses Neuronal-Specific Gene Expression in Maturing Neuronal Progenitor Cells Exposed to HIV. (Q38435698) (← links)
- An Overview of Human Immunodeficiency Virus Type 1-Associated Common Neurological Complications: Does Aging Pose a Challenge? (Q38628801) (← links)
- Differentiating HIV-Associated Neurocognitive Disorders From Alzheimer's Disease: an Emerging Issue in Geriatric NeuroHIV. (Q38639562) (← links)
- Fingolimod induces neuronal-specific gene expression with potential neuroprotective outcomes in maturing neuronal progenitor cells exposed to HIV. (Q40039541) (← links)
- Microwave & magnetic proteomics of macrophages from patients with HIV-associated cognitive impairment (Q40107495) (← links)
- Multilevel analysis of neuropathogenesis of neurocognitive impairment in HIV. (Q40241936) (← links)
- Plasma soluble CD163 is associated with postmortem brain pathology in human immunodeficiency virus infection (Q40314419) (← links)
- Extracellular vesicles of the blood-brain barrier: Role in the HIV-1 associated amyloid beta pathology. (Q40389352) (← links)
- Soluble TLR2 and 4 concentrations in cerebrospinal fluid in HIV/SIV-related neuropathological conditions. (Q40437527) (← links)
- ApoE ε4 Is Associated With Cognition, Brain Integrity, and Atrophy in HIV Over Age 60. (Q40481227) (← links)
- Lifetime methamphetamine dependence is associated with cerebral microgliosis in HIV-1-infected adults (Q40705923) (← links)
- Molecular Mechanisms for Herpes Simplex Virus Type 1 Pathogenesis in Alzheimer's Disease (Q51761118) (← links)
- BACE1 Mediates HIV-Associated and Excitotoxic Neuronal Damage Through an APP-Dependent Mechanism. (Q52720530) (← links)
- Withaferin A Suppresses Beta Amyloid in APP Expressing Cells: Studies for Tat and Cocaine Associated Neurological Dysfunctions (Q57821144) (← links)
- Risk Factors and Pathogenesis of HIV-Associated Neurocognitive Disorder: The Role of Host Genetics (Q59350870) (← links)
- Aging and Apolipoprotein E in HIV Infection (Q59357369) (← links)
- Genetic, Transcriptome, Proteomic, and Epidemiological Evidence for Blood-Brain Barrier Disruption and Polymicrobial Brain Invasion as Determinant Factors in Alzheimer's Disease (Q64361136) (← links)
- Sestrins at the Interface of ROS Control and Autophagy Regulation in Health and Disease. (Q64885955) (← links)
- Association of antiretroviral therapy with brain aging changes among HIV-infected adults (Q89134743) (← links)
- Extracellular vesicle-mediated amyloid transfer to neural progenitor cells: implications for RAGE and HIV infection (Q89746353) (← links)
- Chronic inflammation mediates brain injury in HIV infection: relevance for cure strategies (Q90630528) (← links)
- HIV-1 infection and latency-reversing agents bryostatin-1 and JQ1 disrupt amyloid beta homeostasis in human astrocytes (Q91589145) (← links)
- HIV Infection Induces Extracellular Cathepsin B Uptake and Damage to Neurons (Q92382293) (← links)
- Associations of regional amyloid-β plaque and phospho-tau pathology with biological factors and neuropsychological functioning among HIV-infected adults (Q92390527) (← links)